XML 59 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Reporting (Tables)
12 Months Ended
Jun. 30, 2021
Segment Reporting  
Segment financial information

Year Ended June 30, 

2021

    

2020

(In thousands)

Consolidated revenue:

  

 

  

Aytu BioPharma

$

32,678

$

17,249

Aytu Consumer Health

 

32,954

 

10,383

Consolidated revenue

$

65,632

$

27,632

Consolidated net loss:

 

  

 

  

Aytu BioPharma

$

(50,529)

$

(10,464)

Aytu Consumer Health

 

(7,760)

 

(3,157)

Consolidated net loss

$

(58,289)

$

(13,621)

June 30, 

2021

2020

(In thousands)

Total assets:

 

  

 

  

Aytu BioPharma

$

236,449

$

126,724

Aytu Consumer Health

 

29,219

 

26,569

Consolidated assets

$

265,668

$

153,293